MarketCap
Achieve Life Sciences ACHV
$ 6.78
0.15%
Facebook
X
Telegram
Country |
 USA |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
43.6 M |
Market Cap[1] |
$ 296 M |
EBITDA (LTM) |
$ 228 K |
P/E (LTM) |
-4.985294 |
P/S (LTM) |
- |
EPS (LTM) |
-1.36 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Oramed Pharmaceuticals
ORMP
|
$ 3.97 | -0.75 % | $ 164 M | Nasdaq Global Select Market |  Israel |
 |
Tyme Technologies
TYME
|
- | 8.07 % | $ 54 M | Nasdaq Capital Market | USA |
 |
Puma Biotechnology
PBYI
|
$ 8.13 | -3.22 % | $ 407 M | Nasdaq Global Select Market | USA |
 |
PDS Biotechnology Corporation
PDSB
|
$ 1.02 | -5.09 % | $ 47.3 M | Nasdaq Capital Market | USA |
 |
Cyclerion Therapeutics
CYCN
|
$ 34.99 | 3.77 % | $ 147 M | Nasdaq Global Select Market | USA |
 |
Pfizer
PFE
|
$ 29.34 | 0.36 % | $ 167 B | NYSE,SPB | USA |
 |
Завод ДИОД
DIOD
|
- | - | - | MOEX,SPB |  Russia |
 |
PainReform Ltd.
PRFX
|
$ 0.78 | -4.24 % | $ 505 K | Nasdaq Capital Market | Israel |
 |
Prothena Corporation plc
PRTA
|
$ 8.56 | -2.51 % | $ 461 M | Nasdaq Global Select Market,SPB | USA |
 |
Arcus Biosciences
RCUS
|
$ 18.66 | -1.56 % | $ 2 B | NYSE,SPB | USA |
 |
Orgenesis
ORGS
|
- | -33.86 % | $ 61.2 M | Nasdaq Capital Market | USA |
 |
Dr. Reddy's Laboratories Limited
RDY
|
$ 14.9 | -1.03 % | $ 12.4 B | NYSE |  India |
 |
Regeneron Pharmaceuticals
REGN
|
$ 916.16 | -0.41 % | $ 95.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Replimune Group
REPL
|
$ 23.3 | 4.67 % | $ 2.16 B | Nasdaq Global Select Market | USA |
 |
Фармсинтез
LIFE
|
- | - | - | MOEX | Russia |
 |
Royalty Pharma plc
RPRX
|
$ 69.47 | 1.02 % | $ 29.9 B | Nasdaq Global Select Market | USA |
 |
Revolution Medicines
RVMD
|
$ 193.0 | -3.57 % | $ 36.7 B | Nasdaq Global Select Market | USA |
 |
Rhythm Pharmaceuticals
RYTM
|
$ 113.99 | 0.04 % | $ 7.41 B | Nasdaq Global Market,SPB | USA |
 |
Codiak BioSciences
CDAK
|
- | -55.98 % | $ 2.15 M | Nasdaq Global Market | USA |
 |
Sana Biotechnology
SANA
|
$ 2.43 | -1.42 % | $ 615 M | Nasdaq Global Select Market | USA |
 |
Sol-Gel Technologies Ltd.
SLGL
|
$ 61.81 | 0.11 % | $ 172 M | Nasdaq Global Select Market | Israel |
 |
Summit Therapeutics
SMMT
|
$ 17.78 | -0.34 % | $ 13.3 B | Nasdaq Global Select Market |  Britain |
 |
Checkpoint Therapeutics
CKPT
|
- | - | $ 169 M | Nasdaq Capital Market | USA |
 |
Syndax Pharmaceuticals
SNDX
|
$ 9.43 | -0.89 % | $ 817 M | Nasdaq Global Select Market | USA |
 |
Spero Therapeutics
SPRO
|
$ 1.01 | -5.61 % | $ 56.6 M | Nasdaq Global Select Market | USA |
 |
Sarepta Therapeutics
SRPT
|
$ 16.4 | -5.54 % | $ 1.64 B | Nasdaq Global Select Market,SPB | USA |
 |
Tarsus Pharmaceuticals
TARS
|
$ 73.9 | 4.32 % | $ 3.09 B | Nasdaq Global Select Market | USA |
 |
Bio-Techne Corporation
TECH
|
$ 72.83 | -0.01 % | $ 11.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Sage Therapeutics
SAGE
|
- | - | $ 527 M | Nasdaq Global Select Market,SPB | USA |
 |
Taro Pharmaceutical Industries Ltd.
TARO
|
- | - | $ 1.62 B | NYSE | Israel |
 |
Cabaletta Bio
CABA
|
$ 1.43 | -5.0 % | $ 144 M | Nasdaq Global Select Market | USA |
 |
Forma Therapeutics Holdings
FMTX
|
- | - | $ 958 M | Nasdaq Global Market | USA |
 |
Blueprint Medicines Corporation
BPMC
|
- | - | $ 8.14 B | Nasdaq Global Select Market,SPB | USA |
 |
Horizon Therapeutics Public Limited Company
HZNP
|
- | - | $ 26.6 B | Nasdaq Global Select Market |  Irlanda |
 |
Tonix Pharmaceuticals Holding Corp.
TNXP
|
$ 4.12 | -8.35 % | $ 35.1 M | Nasdaq Global Select Market | USA |
 |
Paratek Pharmaceuticals
PRTK
|
- | - | $ 121 M | Nasdaq Global Market | USA |
 |
DBV Technologies S.A.
DBVT
|
$ 11.55 | 4.52 % | $ 1.61 B | Nasdaq Global Select Market |  France |
 |
Gilead Sciences
GILD
|
$ 170.68 | 0.8 % | $ 212 B | Nasdaq Global Select Market,SPB | USA |
 |
Taysha Gene Therapies
TSHA
|
$ 4.28 | -2.06 % | $ 1.37 B | Nasdaq Global Select Market | USA |
 |
ASLAN Pharmaceuticals Limited
ASLN
|
- | -14.27 % | $ 1.7 M | Nasdaq Global Market |  Singapore |
 |
Adverum Biotechnologies
ADVM
|
- | - | $ 86.2 M | Nasdaq Global Market | USA |
 |
Unity Biotechnology
UBX
|
- | -33.41 % | $ 3.37 M | Nasdaq Global Select Market | USA |
 |
iTeos Therapeutics
ITOS
|
- | - | $ 411 M | Nasdaq Global Market | USA |
 |
Gossamer Bio
GOSS
|
$ 11.2 | 5.21 % | $ 2.56 B | Nasdaq Global Select Market,SPB | USA |
 |
GeoVax Labs
GOVX
|
$ 0.11 | -22.17 % | $ 105 K | Nasdaq Global Select Market | USA |
 |
United Therapeutics Corporation
UTHR
|
$ 588.33 | 1.01 % | $ 26.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Seelos Therapeutics
SEEL
|
- | -47.76 % | $ 6.27 M | Nasdaq Capital Market | USA |
 |
Vericel Corporation
VCEL
|
$ 59.02 | 1.08 % | $ 2.97 B | Nasdaq Global Select Market,SPB | USA |
 |
Veracyte
VCYT
|
$ 24.05 | -7.21 % | $ 1.89 B | Nasdaq Global Market,SPB | USA |
 |
Advaxis
ADXS
|
- | -9.65 % | $ 45.9 M | Nasdaq Capital Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.